1
Q
PROPEL Study
A
This study looks at the effect of Olaparib in patients with metastatic castration resistant prostate cancer.
2
Q
Acalabrutinib (CALQUENCE)
A
This drug is similar to ibrutinib but is more specific and potent for the BTK receptor in CLL cells.
Biotech
flashcards
Decks in class (11)
# Cards
